$Protagonist Therapeutics, Inc. Common Stock(PTGX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-07 AccNo: 0001193125-17-073383 Size: 7 MB 网页链接